Direct cardiac or systemic? Reexamining the cardiovascular mechanisms of SGLT2 inhibitors and GLP-1 receptor agonists

Journal of basic and clinical physiology and pharmacology · 2026 Nov 5 · Osmanlli A, Conforto R, Roy J et

By Maren Holt · Senior Reporter, GLP-1

Nov 4 13:00 ETSource: Journal of basic and clinical physiology and pharmacology

From the source

Direct cardiac or systemic? Reexamining the cardiovascular mechanisms of SGLT2 inhibitors and GLP-1 receptor agonists
Journal of basic and clinical physiology and pharmacology · 2026 Nov 5 · Osmanlli A, Conforto R, Roy J et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42980595/